BOCA BIOLISTICS LLC
Boca Biolistics is a hybrid CRO leveraging our vertically integrated model to build a life sciences biorepository with industry leading clinical and molecular data sets. Our commercial biobank has 800,000 specimens available for use in R&D as well as clinical trials. Our CLIA/CAP accredited reference lab offers clinical testing as well as research testing services for diagnostic and pharma. Our CRO division provides end-to-end services for both diagnostic and biopharma clinical trials.
Country/Area ：United States
Company Email ：contact@bocabio.com
Industry ：BiotechnologyBusiness ServicesBusiness Services General
Company address ：BLVD. W. HILLSBORO COCONUT CREEK 33073
Company website ：*****
Company phone ：(954) 449-6126
Established ：2009-01-01
Company Revenue ：$3,018,000
Number of employees ：11-50
SIC Code ：80807
NAICS Code ：62621
Company News
Generational Equity Advises Boca Biolistics in its Investment by Clairvest
Feb 28, 2023
DALLAS--(BUSINESS WIRE)--Clairvest invests in Boca Biolistics, an Generational Equity client.
Feb 28, 2023
Clairvest invests $25m in biomaterials company Boca BiolisticsFeb 22, 2023
Boca Biolistics is focused on the procurement, storage and sale of human biological sample used for clinical trials and diagnostic development. The post Clairvest invests $25m in biomaterials company Boca Biolistics appeared first on PE Hub.
Feb 22, 2023Clairvest Re-Enters Life Sciences Industry with Investment in Boca BiolisticsFeb 21, 2023
TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) (“CVG”) today announced that it, together with Clairvest Equity Partners VI (“CEP VI”, collectively “Clairvest”) has made a US$25 million equity investment in Boca Biolistics (“Boca” or the “Company”), partnering with its management team for the next phase of growth.
Feb 21, 2023Biobanking Services Market 2022 COVID 19 Impact Analysis, New Technology, Demand and Opportunity Top Companies Are Qiagen N.V., Hamilton, Brooks Automation, TTP Labtech, VWR, Promega, LGC, Boca BiolisticsFeb 21, 2022
London, UK -- (SBWIRE) -- 02/21/2022 -- Biobanking Services Market size is USD million in 2022 from USD 5004.3 million in 2021, with a change of % between 2021 and 2022. The global Biobanking Services market size will reach USD 8341.9 million in 2028, growing at a CAGR of 7.6% over the analysis period. A Biobanking Services Market studies report includes a top view of the global agency in addition to an in-depth assessment of
Feb 21, 2022Pictor Successfully Completes Validation Trial in U.S. for its...Jan 20, 2022
The Pictor test simultaneously detects the presence of both anti-Spike (SP) antibody and anti-Nucleocapsid (NP) antibody in a single test. (PRWeb January 20, 2022) Read the full story at https://www.prweb.com/releases/pictor_successfully_completes_validation_trial_in_u_s_for_its_sars_co_v_2_antibody_test/prweb18430082.htm
Jan 20, 2022Web Summary
Q1: What is the physical address of Boca Biolistics LLC?
A1: The physical address of Boca Biolistics LLC is 5001 NW 13th Ave, Suite H, Pompano Beach, FL, 33064 USA.
Q2: What types of products or services does Boca Biolistics offer?
A2: Boca Biolistics offers a range of products and services related to biospecimen procurement, biostorage, central laboratory testing, and clinical research studies. These include custom biospecimen procurement, biostorage services, central laboratory testing, and project management for clinical trials.
Q3: What industries or fields does Boca Biolistics specialize in?
A3: Boca Biolistics specializes in the fields of cancer, infectious disease, sexually transmitted infections, autoimmune diseases, GI/microbiome research, and global healthcare.
Q4: How can customers contact Boca Biolistics for support or inquiries?
A4: Customers can contact Boca Biolistics through email at [email protected] or phone at (954) 449-6126. They can also access the customer portal for additional information and resources.
Q5: What is the purpose of the Biospecimens Inventory section on the company's website?
A5: The Biospecimens Inventory section appears to be a placeholder, as it does not contain any specific information or content. However, it may serve as a future development area for the company to showcase their biospecimen inventory and related services.
Q6: What is the significance of Boca Biolistics' acquisition by Clairvest in 2023?
A6: The acquisition by Clairvest in 2023 suggests that Boca Biolistics has received significant investment and support from Clairvest, which may enable the company to expand its operations, invest in new technologies, and accelerate its research and development efforts.
Q7: What is the focus of Boca Biolistics' blog section?
A7: The blog section appears to be focused on providing insights and information related to biospecimen molecular diagnostic testing, emerging SARS-CoV-2 variants, HBV research, and other topics relevant to the company's areas of expertise. The blog may serve as a resource for customers, researchers, and healthcare professionals.
Q8: What is the purpose of the Data Usage Agreement on Boca Biolistics' website?
A8: The Data Usage Agreement appears to be a standard disclaimer or terms-of-use document that outlines the company's policies and procedures for data usage, sharing, and protection. It may serve as a legal framework for the company to ensure compliance with relevant regulations and standards.
Q9: What is Boca Biolistics' expertise in clinical research studies?
A9: Boca Biolistics has expertise in various aspects of clinical research studies, including project management, site management, clinical trial expertise, precision studies, validation studies, method comparison studies, and more. The company appears to be well-equipped to support researchers and healthcare professionals in designing, conducting, and analyzing clinical trials.
Q10: What is Boca Biolistics' commitment to innovation and collaboration?
A10: Boca Biolistics appears to be committed to driving innovation and collaboration in the field of global healthcare. The company's blog section highlights its efforts to accelerate discoveries with cutting-edge technologies and partnerships, suggesting a strong focus on advancing medical research and improving patient outcomes.
A1: The physical address of Boca Biolistics LLC is 5001 NW 13th Ave, Suite H, Pompano Beach, FL, 33064 USA.
Q2: What types of products or services does Boca Biolistics offer?
A2: Boca Biolistics offers a range of products and services related to biospecimen procurement, biostorage, central laboratory testing, and clinical research studies. These include custom biospecimen procurement, biostorage services, central laboratory testing, and project management for clinical trials.
Q3: What industries or fields does Boca Biolistics specialize in?
A3: Boca Biolistics specializes in the fields of cancer, infectious disease, sexually transmitted infections, autoimmune diseases, GI/microbiome research, and global healthcare.
Q4: How can customers contact Boca Biolistics for support or inquiries?
A4: Customers can contact Boca Biolistics through email at [email protected] or phone at (954) 449-6126. They can also access the customer portal for additional information and resources.
Q5: What is the purpose of the Biospecimens Inventory section on the company's website?
A5: The Biospecimens Inventory section appears to be a placeholder, as it does not contain any specific information or content. However, it may serve as a future development area for the company to showcase their biospecimen inventory and related services.
Q6: What is the significance of Boca Biolistics' acquisition by Clairvest in 2023?
A6: The acquisition by Clairvest in 2023 suggests that Boca Biolistics has received significant investment and support from Clairvest, which may enable the company to expand its operations, invest in new technologies, and accelerate its research and development efforts.
Q7: What is the focus of Boca Biolistics' blog section?
A7: The blog section appears to be focused on providing insights and information related to biospecimen molecular diagnostic testing, emerging SARS-CoV-2 variants, HBV research, and other topics relevant to the company's areas of expertise. The blog may serve as a resource for customers, researchers, and healthcare professionals.
Q8: What is the purpose of the Data Usage Agreement on Boca Biolistics' website?
A8: The Data Usage Agreement appears to be a standard disclaimer or terms-of-use document that outlines the company's policies and procedures for data usage, sharing, and protection. It may serve as a legal framework for the company to ensure compliance with relevant regulations and standards.
Q9: What is Boca Biolistics' expertise in clinical research studies?
A9: Boca Biolistics has expertise in various aspects of clinical research studies, including project management, site management, clinical trial expertise, precision studies, validation studies, method comparison studies, and more. The company appears to be well-equipped to support researchers and healthcare professionals in designing, conducting, and analyzing clinical trials.
Q10: What is Boca Biolistics' commitment to innovation and collaboration?
A10: Boca Biolistics appears to be committed to driving innovation and collaboration in the field of global healthcare. The company's blog section highlights its efforts to accelerate discoveries with cutting-edge technologies and partnerships, suggesting a strong focus on advancing medical research and improving patient outcomes.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
